Cargando…
Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes
Chagas disease is an illness caused by the protozoan parasite Trypanosoma cruzi, affecting more than 7 million people in the world. Benznidazole and nifurtimox are the only drugs available for treatment and in addition to causing several side effects, are only satisfactory in the acute phase of the...
Autores principales: | Matutino Bastos, Tanira, Botelho Pereira Soares, Milena, Haddad Franco, Caio, Alcântara, Laura, Antonini, Lorenzo, Sabatino, Manuela, Mautone, Nicola, Holanda Freitas-Junior, Lucio, Moraes, Carolina Borsoi, Ragno, Rino, Rotili, Dante, Schenkman, Sergio, Mai, Antonello, Silvio Moretti, Nilmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279216/ https://www.ncbi.nlm.nih.gov/pubmed/32455951 http://dx.doi.org/10.3390/ijms21103659 |
Ejemplares similares
-
Chemical Constituents of Anacardium occidentale as Inhibitors of Trypanosoma cruzi Sirtuins
por: Matutino Bastos, Tanira, et al.
Publicado: (2019) -
Mitochondrial Sirtuin TcSir2rp3 Affects TcSODA Activity and Oxidative Stress Response in Trypanosoma cruzi
por: dos Santos Moura, Leila, et al.
Publicado: (2021) -
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents
por: Efstathiou, Antonia, et al.
Publicado: (2018) -
A Membrane-bound eIF2 Alpha Kinase Located in Endosomes Is Regulated by Heme and Controls Differentiation and ROS Levels in Trypanosoma cruzi
por: da Silva Augusto, Leonardo, et al.
Publicado: (2015) -
Trypanin Disruption Affects the Motility and Infectivity of the Protozoan Trypanosoma cruzi
por: Saenz-Garcia, Jose L., et al.
Publicado: (2022)